ORCID as entered in ROS

Select Publications
2024, 'A cross section of inflammatory bowel disease management in older persons in Australasia: Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 188 - 189
,2024, 'Comparison of drug tolerant assays for the measurement of bound anti-infliximab antibodies in patient serum', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 150 - 150
,2024, 'Development and validation of a convolutional neural network model in the detection of Crohn's disease erosions and ulcers by pan-enteric wireless capsule endoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 195 - 196
,2024, 'Intestinal ultrasound in immune checkpoint inhibitor-related colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 214 - 215
,2024, 'Post operative recurrence and surgical outcomes following Crohn's ileocolic resections in Australia (PORSCIA study)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 248 - 249
,2024, 'The real-world use of five aminosalicylate treatment for ulcerative colitis: Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 181 - 182
,2024, 'The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy: The Risk Assessment of drug-bound anti-drug-antibodies for Predicting immunogenicity during Immunomodulator De-escalation to Infliximab Monotherapy (RAPIDIM) Study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 211 - 212
,2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Baseline endoscopic activity and concomitant medications in the prediction of oral fecal microbiota therapeutic efficacy in mild-moderate ulcerative colitis: Lyophilised Oral Faecal Microbiota Transplantation for Ulcerative Colitis (LOTUS) study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 170 - 171, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A149 - A150, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.207
,2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Lyophilised Oral Faecal Microbiota Transplantation in the Management of Ulcerative Colitis (LOTUS Study): Results from the induction phase of a randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 116 - 117, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Vitamin D deficiency in Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S152 - S153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318900247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,